Judge Vacates Summary Judgment, Revives Corixa's Suit Vs. Biogen Idec

Law360, New York (January 23, 2004, 12:00 AM EST) -- A U.S. judge has revived biotechnology company Corixa Corp.'s lawsuit against rival Biogen Idec Inc. over patents for Corixa’s Bexxar cancer drug.

U.S. Judge Irma Gonzalez of the U.S. District Court for the Southern District of California vacated an Oct. 14, 2003 summary judgment in favor of Biogen Idec based on new evidence, as well as other evidence not previously considered, according to Corixa.

As a result of the court's order, the previous ruling declaring Corixa's patents unenforceable has been reversed and the pending litigation regarding...
To view the full article, register now.